JP Morgan Chase’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.39M | Sell |
548,491
-195,207
| -26% | -$2.49M | ﹤0.01% | 3095 |
|
|
2025
Q4 | $6.69M | Buy |
743,698
+303,126
| +69% | +$4.17M | ﹤0.01% | 3055 |
|
|
2025
Q3 | $7.61M | Sell |
440,572
-499,911
| -53% | -$6.16M | ﹤0.01% | 2964 |
|
|
2025
Q2 | $8.82M | Buy |
940,483
+396,858
| +73% | +$3.26M | ﹤0.01% | 2669 |
|
|
2025
Q1 | $3.87M | Sell |
543,625
-14,893
| -3% | -$150K | ﹤0.01% | 3382 |
|
|
2024
Q4 | $6.51M | Sell |
558,518
-90,536
| -14% | -$1.41M | ﹤0.01% | 3108 |
|
|
2024
Q3 | $13.3M | Sell |
649,054
-20,051
| -3% | -$462K | ﹤0.01% | 2354 |
|
|
2024
Q2 | $15M | Buy |
669,105
+125,998
| +23% | +$3M | ﹤0.01% | 2104 |
|
|
2024
Q1 | $14.9M | Sell |
543,107
-93,010
| -15% | -$2.58M | ﹤0.01% | 2138 |
|
|
2023
Q4 | $19.4M | Buy |
636,117
+21,101
| +3% | +$606K | ﹤0.01% | 1887 |
|
|
2023
Q3 | $19.4M | Sell |
615,016
-38,334
| -6% | -$1.49M | ﹤0.01% | 1701 |
|
|
2023
Q2 | $26.6M | Sell |
653,350
-17,782
| -3% | -$721K | ﹤0.01% | 1500 |
|
|
2023
Q1 | $25M | Buy |
671,132
+8,515
| +1% | +$334K | ﹤0.01% | 1503 |
|
|
2022
Q4 | $23.1M | Buy |
662,617
+21,770
| +3% | +$1.04M | ﹤0.01% | 1557 |
|
|
2022
Q3 | $35.9M | Sell |
640,847
-1,617
| -0.3% | -$100K | 0.01% | 1211 |
|
|
2022
Q2 | $33.3M | Buy |
642,464
+14,495
| +2% | +$736K | ﹤0.01% | 1267 |
|
|
2022
Q1 | $45.6M | Sell |
627,969
-40,398
| -6% | -$3.42M | 0.01% | 1213 |
|
|
2021
Q4 | $79M | Buy |
668,367
+174,640
| +35% | +$21.9M | 0.01% | 990 |
|
|
2021
Q3 | $66.2M | Sell |
493,727
-402,850
| -45% | -$61M | 0.01% | 1048 |
|
|
2021
Q2 | $145M | Sell |
896,577
-5,357
| -0.6% | -$417K | 0.02% | 731 |
|
|
2021
Q1 | $72.4M | Buy |
901,934
+284,110
| +46% | +$19.1M | 0.01% | 998 |
|
|
2020
Q4 | $33.6M | Buy |
617,824
+189,628
| +44% | +$6.89M | 0.01% | 1278 |
|
|
2020
Q3 | $9.25M | Buy |
428,196
+117,915
| +38% | +$2.46M | ﹤0.01% | 2099 |
|
|
2020
Q2 | $6.52M | Buy |
310,281
+86,659
| +39% | +$1.47M | ﹤0.01% | 2251 |
|
|
2020
Q1 | $2.73M | Buy |
223,622
+97,807
| +78% | +$1.32M | ﹤0.01% | 2732 |
|
|
2019
Q4 | $1.85M | Buy |
125,815
+113,140
| +893% | +$1.57M | ﹤0.01% | 3441 |
|
|
2019
Q3 | $169K | Buy |
12,675
+2,675
| +27% | +$42.6K | ﹤0.01% | 4699 |
|
|
2019
Q2 | $152K | Buy |
10,000
+1,894
| +23% | +$29.8K | ﹤0.01% | 4771 |
|
|
2019
Q1 | $138K | Sell |
8,106
-381
| -4% | -$5.68K | ﹤0.01% | 4773 |
|
|
2018
Q4 | $116K | Buy |
8,487
+792
| +10% | +$14.7K | ﹤0.01% | 4789 |
|
|
2018
Q3 | $220K | Buy |
7,695
+947
| +14% | +$27.6K | ﹤0.01% | 4657 |
|
|
2018
Q2 | $185K | Sell |
6,748
-21,136
| -76% | -$512K | ﹤0.01% | 4591 |
|
|
2018
Q1 | $588K | Buy |
27,884
+24,289
| +676% | +$597K | ﹤0.01% | 3942 |
|
|
2017
Q4 | $69K | Buy |
+3,595
| New | +$83K | ﹤0.01% | 4788 |
|
|
2017
Q2 | – | Sell |
-3,302
| Closed | -$47K | – | 5132 |
|
|
2017
Q1 | $47K | Buy |
+3,302
| New | +$44.3K | ﹤0.01% | 4544 |
|
|
2016
Q3 | – | Sell |
-60,925
| Closed | -$1.3M | – | 4716 |
|
|
2016
Q2 | $1.3M | Buy |
+60,925
| New | +$1.62M | ﹤0.01% | 3042 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
